Activity of β-Caryophyllene Oxide Derivatives Against Trypanosoma cruzi, Mammalian Cells, and Horseradish Peroxidase
暂无分享,去创建一个
L. M. Pereira | G. Clososki | G. B. Portapilla | S. de Albuquerque | R. Soldi | G. Portapilla | Inara Fernanda Lage Gallo | Péricles Gama Abreu Filho
[1] K. Hardy. Paleomedicine and the Evolutionary Context of Medicinal Plant Use , 2020, Revista Brasileira de Farmacognosia.
[2] Thomas N. Rohrabaugh,et al. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands. , 2020, Dalton transactions.
[3] Chhandak Basu,et al. Therapeutic and Medicinal Uses of Terpenes , 2019, Medicinal Plants.
[4] S. de Albuquerque,et al. Effect of Fluorination on the Structure and Anti-Trypanosoma cruzy Activity of Oxorhenium(V) Complexes with S,N,S-Tridentate Thiosemicarbazones and Benzoylthioureas. Synthesis and Structures of Technetium(V) Analogues. , 2019, Inorganic chemistry.
[5] M. Wainwright,et al. Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro , 2019, BioMed research international.
[6] D. Engman,et al. Pathology and Pathogenesis of Chagas Heart Disease. , 2019, Annual review of pathology.
[7] M. Petrillo,et al. Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings , 2019, BioMed research international.
[8] I. Molina,et al. Chagas disease , 2018, The Lancet.
[9] R. Tarleton,et al. Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure , 2017, bioRxiv.
[10] Anna Bilska-Wilkosz,et al. The Role of Hemoproteins: Hemoglobin, Myoglobin and Neuroglobin in Endogenous Thiosulfate Production Processes , 2017, International journal of molecular sciences.
[11] S. Basu,et al. Malaria: An Update , 2017, The Indian Journal of Pediatrics.
[12] L. Berná,et al. Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi , 2017, PeerJ.
[13] A. Szumny,et al. β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties , 2016, Cancer medicine.
[14] O. Thiemann,et al. In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug. , 2016, Experimental parasitology.
[15] E. Chatelain. Chagas Disease Drug Discovery , 2015, Journal of biomolecular screening.
[16] F. Escalante-Erosa,et al. Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosoma cruzi , 2013, Evidence-based complementary and alternative medicine : eCAM.
[17] Hyejung Lee,et al. Development and Validation of Acupuncture Fear Scale , 2013, Evidence-based complementary and alternative medicine : eCAM.
[18] W. Setzer,et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. , 2012, Current medicinal chemistry.
[19] Â. Pinto,et al. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. , 2012, Journal of medicinal chemistry.
[20] G. Sethi,et al. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. , 2011, Cancer letters.
[21] Umberto D'Alessandro,et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria , 2011, Malaria Journal.
[22] C. Nakamura,et al. Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi. , 2011, Natural product reports.
[23] P. Covello,et al. Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases , 2011, Phytochemistry Reviews.
[24] L. I. Kas’yan,et al. Methods and mechanisms of epoxy compounds reduction , 2008 .
[25] Atta-ur-rahman,et al. Microbial transformation and butyrylcholinesterase inhibitory activity of (-)-caryophyllene oxide and its derivatives. , 2006, Journal of natural products.
[26] S. Ward,et al. Access to hematin: the basis of chloroquine resistance. , 1998, Molecular pharmacology.
[27] L V Kirchhoff,et al. Chagas disease. American trypanosomiasis. , 1993, Infectious disease clinics of North America.
[28] R. Isturiz,et al. Chagas Disease , 2021, Neglected Tropical Diseases.
[29] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[30] J. Mee. The synergistic effect , 1965 .